NCT03358303Active, not recruiting
Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation
Effect of a Mobile Phone-based Telemonitoring Program on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
Heart failure is the most rapidly rising cardiovascular disease and has come to be recognized as a growing epidemic. Digital health interventions are the most recent iteration of an effort to promote individualized outpatient care through positive behaviour change theory. The UHN team has developed a highly automated and user-centered smartphone-based system, Medly, which allows for the telemonitoring of patients diagnosed with heart failure. The purpose of this study will be two-fold: 1) to determine if the introduction of Medly within two weeks of discharge will improve self-care management, quality of life, and clinical status, 2) to assess whether Medly will lead to a potential reduction in 30 day readmission rates amongst HF patients in the Toronto Central Local Health Integration Network (TC LHIN), without increasing the average length of stay or visits to the emergency department. These parameters will be measured as secondary outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 24 Nov 2017
- Start date
- 16 Nov 2018
- Primary completion date
- 1 Sept 2023
- Lead sponsor
- University Health Network, Toronto
- Diseases
- Heart failure
- NCT number
- NCT03358303
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 16 Nov 2018 to the primary completion date, 1 Sept 2023
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Dementia or uncontrolled psychiatric illness
- Terminal diagnosis of any health condition with a life expectancy \< 1 year
Other
- Residents of long-term care facilities
- Patients who will require inpatient rehabilitation after discharge
- Participating in another clinical trial that may confound the results
Who the study is looking for
- Adults (18 years or older)
- Hospitalization for decompensated HF \> 48 hours
- Patient speaks and reads English adequately to provide informed consent and understand the text prompts in the application (or has an informal caregiver who can translate for them)
- Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| North York General Hospital Coordinator of this site? Confirm its status | North York | Canada | Unknown status |
| Mount Sinai Hospital Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
| Sunnybrook Health Sciences Centre Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.